Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-29

Clinical Trial Update: A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

Sanofi's Phase 2 trial of SAR442970 in adults with hidradenitis suppurativa has completed and results have been posted. The study evaluated the efficacy and saf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SAR442970

Snippet

Sponsor: Sanofi | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED | Results posted: 2026-01-29